EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical correlates of lipoprotein (a) and apolipoprotein B levels in patients with dyslipidemia and cardiovascular disease

Luana Alexandrescu, Daria Maria Alexandrescu, Ionut Tiberiu Tofolean, Doina Ecaterina Tofolean, Steliana Pindichi, Eugen Dumitru, Bogdan Campineanu, Cristina Aftenie, Andreea Nelson Twakor, Alexandra Herlo, Elena Rusu, Diana Raluca Baicu und 3 weitere

Frontiers in Cardiovascular Medicine · 09.07.2026 · 13

DOI: 10.3389/fcvm.2026.1821490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 09.07.2026. Verfasst von Luana Alexandrescu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, "Sf. Apostol Andrei" Emergency County Hospital, Constanta, Romania. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atherosclerotic cardiovascular disease remains a major cause of morbidity and mortality worldwide, with residual cardiovascular risk persisting despite optimized lipid-lowering therapy. Lipoprotein(a) [Lp(a)] and apolipoprotein B (ApoB) have emerged as independent, causal biomarkers of cardiovascular risk, reflecting atherogenic particle burden beyond conventional lipid measures. This study aimed to evaluate the clinical, metabolic, and biochemical correlates of Lp(a) and ApoB levels in patients with dyslipidemia and cardiovascular disease.

Methods

A cross-sectional observational analysis was performed in 153 adults evaluated for cardiometabolic risk. Anthropometric, biochemical, and inflammatory parameters were assessed. Correlation analyses were conducted to identify associations between lipoproteins and metabolic variables. Decision tree regression was used to explore distribution patterns of Lp(a) and ApoB variability.

Results

The study population exhibited a mean age of 57.9 ± 12.3 years, with a predominance of dyslipidemia (79.1%) and established cardiovascular disease (75.2%). The mean Lp(a) concentration was 30.14 ± 31.50 mg/dL, while ApoB averaged 119.87 ± 36.01 mg/dL. ApoB correlated significantly with total cholesterol ( r = 0.49, p < 0.001), triglycerides ( r = 0.46, p < 0.001), and LDL-C ( r = 0.26, p < 0.01). Decision tree analysis identified GGT, creatinine, and uric acid as factors that influence of Lp(a) variability.

Conclusions

Both hepatic and renal function markers significantly modulate Lp(a) levels, while ApoB remains a robust indicator of atherogenic particle load. Integrating Lp(a) and ApoB assessment into cardiovascular risk profiling may improve identification of residual risk and guide personalized therapeutic strategies in dyslipidemic populations.

Schlagwörter

Stichwörter der Autor:innen

apolipoprotein Bcardiovascular diseasecreatininedyslipidemiagamma-glutamyl transferaselipoprotein(a)uric acid

Autor:innen und Institutionen

  • Gastroenterology Department, "Sf. Apostol Andrei" Emergency County Hospital, Constanta, Romania.
  • Medicine Faculty, "Ovidius" University of Constanta, Constanta, Romania.
  • Faculty of Medicine, Titu Maiorescu University, Bucharest, Romania.
  • Pneumology Department, Sf. Apostol Andrei" Emergency County Hospital, Constanta, Romania.
  • Doctoral School, Medicine Faculty, "Ovidius" University of Constanta, Constanta, Romania.
  • Nephrology Department, "Sf. Apostol Andrei" Emergency County Hospital, Constanta, Romania.

Zitieren

APA

Alexandrescu, L., Alexandrescu, D. M., Tofolean, I. T., Tofolean, D. E., Pindichi, S., Dumitru, E., Campineanu, B., Aftenie, C., Nelson Twakor, A., Herlo, A., Rusu, E., Baicu, D. R., Ilie, M., Berariu, F. V., & Condur, L. M. (2026). Clinical correlates of lipoprotein (a) and apolipoprotein B levels in patients with dyslipidemia and cardiovascular disease. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1821490

Vancouver

Alexandrescu L, Alexandrescu DM, Tofolean IT, Tofolean DE, Pindichi S, Dumitru E, et al. Clinical correlates of lipoprotein (a) and apolipoprotein B levels in patients with dyslipidemia and cardiovascular disease. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1821490

BibTeX
@article{Alexandrescu2026,
  author = {Alexandrescu, Luana and Alexandrescu, Daria Maria and Tofolean, Ionut Tiberiu and Tofolean, Doina Ecaterina and Pindichi, Steliana and Dumitru, Eugen and Campineanu, Bogdan and Aftenie, Cristina and Nelson Twakor, Andreea and Herlo, Alexandra and Rusu, Elena and Baicu, Diana Raluca and Ilie, Madalina and Berariu, Filip-Vasile and Condur, Laura Maria},
  title = {Clinical correlates of lipoprotein (a) and apolipoprotein B levels in patients with dyslipidemia and cardiovascular disease},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  volume = {13},
  doi = {10.3389/fcvm.2026.1821490}
}
Kostenlos starten →